GLP-1 Receptor Agonists Investigated for Neuroprotective Effects in Alzheimer’s Disease
Researchers are investigating whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs), medications currently approved for obesity and type 2 diabetes, can be repurposed to treat Alzheimer’s disease (AD). While these drugs … Read More